Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00020506
DRKS00020506
Completed
Not Applicable

The intestinal microbiome as a predictive biomarker for efficacy and side effects of CAR-T cell therapy in blood cancers - MiCART

Deutsches Krebsforschungszentrum (DKFZ)0 sites66 target enrollmentJanuary 20, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsC91.0C83.3Acute lymphoblastic leukaemia [ALL]Diffuse large B-cell lymphoma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C91.0
Sponsor
Deutsches Krebsforschungszentrum (DKFZ)
Enrollment
66
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 20, 2020
End Date
December 28, 2021
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Deutsches Krebsforschungszentrum (DKFZ)

Eligibility Criteria

Inclusion Criteria

  • •lymphoma / leukemia patients with medically indicated CD19 CAR\-T cell therapy
  • •\-persons who have understood the informed consent and signed the written consent form

Exclusion Criteria

  • •\- Refusal by the patient
  • •\- Lack of ability to consent

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Predictive Value of Human Microbiome and Serological Markers for Clinical Outcome of Cerebral HemorrhageHemorrhagic StrokeAcuteOutcomesMetabolitesGut Microbiota
NCT05551923Nanfang Hospital, Southern Medical University300
Recruiting
Not Applicable
Predictive biomarkers and the role of the microbiome determining response to antiinflammatory treatment in Inflammatory Bowel Disease (Crohn's disease and ulcerative colitis)Crohn's diseaseinflammatory Bowel Diseaseulcerative colitis10017969
NL-OMON50413Academisch Medisch Centrum2,240
Recruiting
Not Applicable
Predicting the impact of the gut microbiome on immunosuppressive drug metabolism in kidney transplant patientsKidney Transplantation
DRKS00023398niversitätsklinikum Heidelberg130
Recruiting
Not Applicable
The analysis of the microbiota as biomarkers of response to anticancer drugs in metastatic solid cancers
JPRN-UMIN000030778Department of Internal Medicine, Division of Medical Oncology, Showa University School of Medicine.60
Suspended
Not Applicable
Influence of the intestinal microbiome on the risk of spontaneous bacterial peritonitis in patients with decompensated liver cirrhosisK65K74.6PeritonitisOther and unspecified cirrhosis of liver
DRKS00026834Klinik und Poliklinik für Innere Medizin II Klinikum rechts der Isar der TU München120